CAS No.100678-32-8,Cibenzoline succinate Suppliers,MSDS download

Products Categories

Pharmaceutical (12)
Organic Chemicals (4)
Reagent (1)
Others (1)

Basic Information

CAS No.:

100678-32-8

Name:

Cibenzoline succinate

Molecular Structure:

Formula:

C₁₈H₁₈N₂^.C₄H₆O₄

Molecular Weight:

380.44

Synonyms:

2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1H-imidazole succinate

Density:

g/cm³

Melting Point:

165°

Boiling Point:

449.2°Cat760mmHg

Flash Point:

225.5°C

Hazard Symbols:

Risk Codes:

R22

Safety:

Hazard Codes	Xn
Risk Statements	22
RTECS	EJ9960100

PSA:

98.99000

LogP:

2.69450

Country:
Business Type:
All

Lab/Research institutions

Trading Company

Manufacturers

Other
Certificate:
Manufacturer

Enterprise Authentication

ISO

GMP

FDA

HALAL

Display:default sort
Suppiers of more reward points first

New supplier

Total:17 Page 1 of 1 1

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 100678-32-8

Chemistry

IUPAC Name: Butanedioic acid; 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole
Canonical SMILES: C1CN=C(N1)C2CC2(C3=CC=CC=C3)C4=CC=CC=C4.C(CC(=O)O)C(=O)O
InChI: InChI=1S/C18H18N2.C4H6O4/c1-3-7-14(8-4-1)18(15-9-5-2-6-10-15)13-16(18)17-19-11-12-20-17;5-3(6)1-2-4(7)8/h1-10,16H,11-13H2,(H,19,20);1-2H2,(H,5,6)(H,7,8)
InChIKey: XFUIOIWYMHEPIE-UHFFFAOYSA-N
Molecular Weight: 380.43696 [g/mol]
Molecular Formula: C₂₂H₂₄N₂O₄
H-Bond Donor: 3
H-Bond Acceptor: 6
EINECS: 260-856-8
Product Categories: Heterocyclic Compounds
storage temp.: 2-8 °C
Flash Point: 225.5 °C
Enthalpy of Vaporization: 68.06 kJ/mol
Boiling Point: 449.2 °C at 760 mmHg
Vapour Pressure: 7.75E-08 mmHg at 25 °C
Classification Code of Cibenzoline succinate (CAS NO.100678-32-8): Cardiac depressant [anti-arrhythmic]; Drug / Therapeutic Agent; Reproductive Effect

Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LD	oral	> 56mg/kg (56mg/kg)	BEHAVIORAL: TREMOR GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" GASTROINTESTINAL: NAUSEA OR VOMITING	Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4519, 1988.
dog	LD50	intravenous	33300ug/kg (33.3mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) CARDIAC: CHANGE IN RATE GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"	Kiso to Rinsho. Clinical Report. Vol. 25, Pg. 3385, 1991.
mouse	LD50	intraperitoneal	73100ug/kg (73.1mg/kg)	SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988.
mouse	LD50	oral	180mg/kg (180mg/kg)	SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988.
mouse	LD50	subcutaneous	83300ug/kg (83.3mg/kg)	SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)	Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988.
rat	LD50	intraperitoneal	83400ug/kg (83.4mg/kg)	SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988.
rat	LD50	intravenous	44400ug/kg (44.4mg/kg)	SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988.
rat	LD50	oral	359mg/kg (359mg/kg)	SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988.
rat	LD50	subcutaneous	156mg/kg (156mg/kg)	SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988.

Safety Profile

Hazard Codes: Harmful Xn
Risk Statements: 22
R22:Harmful if swallowed.
RTECS of Cibenzoline succinate (CAS NO.100678-32-8): EJ9960100

Specification

Cibenzoline succinate (CAS NO.100678-32-8), its Synonyms are (+-)-2-(2,2-Diphenylcyclopropyl)-2-imidazoline succinate (1:1) ; 1H-Imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-, (+-)-, butanedioate (1:1) ; 1H-Imidazole, 4,5-dihydro-2-(2,2-diphenylcyclopropyl)-, succinate ; 4,5-Dihydro-2-(2,2-diphenylcyclopropyl)-1H-imidazole succinate ; Cibenzoline succinate (1:1) ; Cipralan ; Ritmalan ; Butanedioic acid, compd. with 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole (1:1) .